Nutromics Raises Us$14 Million For Its Ground-Breaking Wearable Diagnostic Platform

Sep 08, 2022•over 3 years ago

Amount Raised

$14 Million

Exploration Park And MelbourneHealth DiagnosticsMedical DeviceBiotechnologyHealth Care

Description

Global MedTech start-up Nutromics has raised an additional US $14 million for its wearable diagnostic platform. This transformative funding is key to Nutromics' continued expansion across Australia and the United States. Strategic investors included Dexcom Ventures, VU Venture Partners, and Artesian Investments.

Company Information

Company

Nutromics

Location

Victoria Street

Exploration Park And Melbourne, Victoria, AUS

About

We are an Australian MedTech company with a vision to create a world with zero preventable deaths due to the lack of timely molecular-level data. We are developing a Continuous Molecular Monitoring platform technology that can provide clinicians with real-time and continuous data for multiple targets. To date, we have raised $10 million, won an award for Technology Platform Solution of the Year at the National iawards, and been a Top 5 finalist in the medTech Innovator program. Our team of 15 are currently working towards our first-in-human clinical trials. Join us on our journey to revolutionise precision medicine and put an end to preventable tragedies.

Related People

2 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Nutromics Raises Us$14 Million For Its Ground-Breaking Wearable Diagnostic Platform

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information